Nuzenio

Endpoints News Updated

Endpoints News Updated entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 9 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Exclusive: FDA outlines expedited IND pilot plans, seeking to pick up to 10 programs by year's end - Endpoints NewsEndpoints News · Thu, 06 Aug 2026 19:17:43 GMTUpdated: Braveheart lands $383M IPO to take Hengrui cardio drug into Phase 3 - Endpoints NewsEndpoints News · Thu, 06 Aug 2026 06:56:00 GMTNovo Nordisk eyes bolt-on deals as pipeline disappointments pile up - Endpoints NewsEndpoints News · Wed, 05 Aug 2026 11:06:00 GMTPfizer keeps cutting, eliminating costs and programs as pipeline delivers mixed results - Endpoints NewsEndpoints News · Tue, 04 Aug 2026 11:36:00 GMTMerck's anti-TL1A antibody scores a win in hidradenitis suppurativa, fails in a rare lung disease - Endpoints NewsEndpoints News · Tue, 04 Aug 2026 10:30:00 GMTExclusive: Pathos AI signs two deals, plans to raise Series E at $3B valuation - Endpoints NewsEndpoints News · Tue, 04 Aug 2026 00:00:00 GMTUpdate: Supernus, Indivior to merge and form CNS-focused drugmaker - Endpoints NewsEndpoints News · Mon, 03 Aug 2026 16:37:33 GMTUpdated: Replimune scores win as FDA advisors back melanoma treatment, bucking staff concerns - Endpoints NewsEndpoints News · Fri, 31 Jul 2026 07:00:00 GMT

Timeline

Thu, 06 Aug 2026 19:17:43 GMTExclusive: FDA outlines expedited IND pilot plans, seeking to pick up to 10 programs by year's end - Endpoints News
Thu, 06 Aug 2026 06:56:00 GMTUpdated: Braveheart lands $383M IPO to take Hengrui cardio drug into Phase 3 - Endpoints News
Wed, 05 Aug 2026 11:06:00 GMTNovo Nordisk eyes bolt-on deals as pipeline disappointments pile up - Endpoints News
Tue, 04 Aug 2026 11:36:00 GMTPfizer keeps cutting, eliminating costs and programs as pipeline delivers mixed results - Endpoints News
Tue, 04 Aug 2026 10:30:00 GMTMerck's anti-TL1A antibody scores a win in hidradenitis suppurativa, fails in a rare lung disease - Endpoints News
Tue, 04 Aug 2026 00:00:00 GMTExclusive: Pathos AI signs two deals, plans to raise Series E at $3B valuation - Endpoints News

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Endpoints News Updated.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.